Medication info
Urinonjeong (Benzbromarone)

Urinonjeong (Benzbromarone)

Prescription medicationTabletOral
Ingredient · strength
Benzbromarone›50mg / 1 tablet
Manufacturer / importer
Hanlim Pharmaceutical Co., Ltd.
Appearance
White round tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 199502668 · Approved 1995.03.27 · Insurance code 645301370

Summary

Main use
Improves hyperuricemia associated with gout and hyperuricemia accompanying hypertension
Who takes it
Adults
Adult dose
Gout Adults: Administer benzbromarone 25 mg or 50 mg orally once daily, then administer a maintenance dose of 50 mg per dose, 1 ∼ 3 times daily. Hypertension with hyperuricemia Adults: Administer 50 mg per dose orally, 1 ∼ 3 times daily. Adjust the dose as appropriate according to symptoms.

Ingredients

Manufacturer
Hanlim Pharmaceutical Co., Ltd.

Efficacy & effects

Improves hyperuricemia associated with gout and hyperuricemia accompanying hypertension

  • Gout
  • hyperuricemia
  • hypertension
View approved original text

This medication is used for conditions associated with hyperuricemia, particularly gout and hypertension accompanied by hyperuricemia. Gout is a condition that occurs due to elevated uric acid levels in the body, and this medication helps to lower blood uric acid levels, thereby alleviating symptoms. Moreover, it contributes to maintaining health by regulating uric acid levels in patients with hypertension associated with hyperuricemia. Through these effects, it assists patients in alleviating symptoms and managing their health.

How to take

Adult dose

Gout Adults: Administer benzbromarone 25 mg or 50 mg orally once daily, then administer a maintenance dose of 50 mg per dose, 1 ∼ 3 times daily. Hypertension with hyperuricemia Adults: Administer 50 mg per dose orally, 1 ∼ 3 times daily. Adjust the dose as appropriate according to symptoms.

Precautions

This medication may cause serious liver impairment mainly within 6 months of starting treatment; hence, regular liver function tests are required for at least 6 months. If liver function test results are abnormal or symptoms of jaundice appear, the medication should be discontinued immediately, and appropriate treatment should be sought. During treatment, if symptoms such as loss of appetite, nausea, vomiting, a feeling of weakness, abdominal pain, diarrhea, fever, urinary tract infection symptoms, or yellowing of the conjunctiva occur, the medication should be stopped right away, and a professional examination should be obtained. This medication should not be used in patients allergic to this drug or bromides, those with a history of kidney stones, those with poor kidney function, pregnant women, or women who may become pregnant. If symptoms such as skin rash, itching, or flushing of the face occur, the medication should be discontinued, and regular liver function tests should be conducted as hepatitis or liver dysfunction may develop. Gastrointestinal symptoms such as digestive disorders, diarrhea, constipation, abdominal pain, and nausea may occur, so caution is necessary. Adequate fluid intake is required during the use of this medication, with a minimum of 1.5–2 liters of beverages daily to prevent uric acid stones or kidney issues. Additionally, this medication may trigger initial gout attacks, so it is recommended to take it alongside other medications used for treating gout when first starting. Patients with high blood pressure may experience side effects more frequently, hence caution is advised. There may be interactions with other medications, particularly when taken with allopurinol, blood thinners, antituberculosis drugs, and aspirin, so consultation with a professional is necessary. Women who are pregnant or breastfeeding are advised not to take this medication, and if it is unavoidable, breastfeeding should be avoided. Safety for children has not been established, so it is preferable not to use it in children. Elderly patients may have decreased body functions, so caution in adjusting dosages is necessary. Finally, this medication should be kept out of reach of children and not transferred to other containers for safety.

Side effects

  • photosensitivity reactions
  • itching
  • hives
  • rash
  • flushing
  • erythema
  • acute severe hepatitis
  • jaundice
  • elevated AST
  • elevated ALT
Show 22 more
  • elevated ALP
  • epigastric discomfort
  • gastrointestinal disturbances
  • diarrhea
  • constipation
  • chest pain
  • loose stools
  • stomach pain
  • abdominal pain
  • nausea
  • symptoms of oral roughness
  • conjunctivitis
  • edema
  • discomfort in the epigastric region
  • headache
  • temporary erectile dysfunction
  • urethritis
  • loss of appetite
  • generalized malaise
  • fever
  • urinary tract infection
  • conjunctival jaundice

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light; therefore, it should be stored in an opaque container that does not allow light in. Furthermore, it is important to keep it at room temperature, avoiding extremes of heat or cold, to maintain the medication’s efficacy.

Appearance and packaging

Appearance

White round tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.